Fig. 5From: Combined atezolizumab and nab-paclitaxel in the treatment of triple negative breast cancer: a meta-analysis on their efficacy and safetyForest plot and meta-analysis results for haematological AEs (A); gastrointestinal AEs (B); liver AEs (C), dermatological AEs (D)Back to article page